Professor David Nutt - The science behind substance and addiction

Joaquin Perez-Grande - How space science helps us to problem solve on Earth

This week we are exploring sustainability in space, the satellite innovation ecosystem, how satellite technology could help solve big issues on our planet, such as cancer treatments, and why communicating space science effectively can be tricky. To discuss this is Joaquin Perez-Grande, Partnerships and Policy Manager (Place) at the Satellite Applications Catapult and 2026 Foundation Future Leader.

Professor David Patterson and Dr Mark James - Interdisciplinary action for our oceans

This week we are discussing the urgent challenges facing the UK’s coasts and seas, balancing protection with demand and how one interdisciplinary group of scientists, policymakers, community and industry experts came together to tackle the problem. To explore how researchers and experts from different sides came together to form the Sustainable Management of UK Marine Resources Network, and the impacts of their work, Professor David Patterson and Dr Mark James of St Andrews University and SMMR champions joined us on the podcast.

Rory Daniels - The UK robotics industry

This week we are discussing robotics, and the UK robotics industry. Here to explore that is Rory Daniels, Head of Emerging Technology and Innovation at TechUK.

Dr Kath MacKay - Life sciences in the UK

This week we are discussing life sciences in the UK, and its contribution to the UK economy. This follows the publication by the Government of the Life Sciences Sector Plan and an event on life sciences which the Foundation for Science and Technology held on 12th November. With us to explore all things life sciences is Dr Kath MacKay, Chief Scientific Officer of Bruntwood SciTech.

Professor David Nutt - The science behind substance and addiction

This week we are discussing the science behind substance and addiction- the impacts of alcohol on the brain and contemporary alternatives, and how psychedelic research and brain science is being combined to tackle depression, addiction and anxiety. With me to explore this is Professor David Nutt, Professor of Neuropsychopharmacology at Imperial College London and Chief Scientific Officer at GABA Labs.